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Abstract 
Background. Many of our daily behaviors are habitual, occurring automatically in response to learned 
contextual cues, and with minimal need for cognitive and self-regulatory resources. Behavioral habit 
strength predicts adherence to actions, including to medications. The time of day (morning vs. evening) 
may influence adherence and habit strength to the degree that stability of contexts/routines varies 
throughout the day. 
Purpose. The current study evaluates whether patients are more adherent to morning versus evening 
doses of medication and if morning doses show evidence of greater habit strength than evening doses. 
Methods. Objective adherence data (exact timing of pill dosing) were collected in an observational study 
by electronic monitoring pill bottles in a sample of patients on twice-daily pills for Type 2 diabetes (N = 
51) over the course of 1 month. 
Results. Data supported the hypothesis that patients would miss fewer morning than evening pills. 
However, counter to the hypothesis, variability in dose timing (an indicator of habit strength) was not 
significantly different for morning versus evening pills. 
Conclusions. Findings suggest that medication adherence may be greater in the morning than in the 
evening. However, more research is needed to evaluate the role of habitual action in this greater 
adherence. Furthermore, future research should evaluate the validity of behavioral timing consistency as 
an indicator of habit strength. 
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Abstract
Background. Many of our daily behaviors are habitual, 
occurring automatically in response to learned con-
textual cues, and with minimal need for cognitive and 
self-regulatory resources. Behavioral habit strength pre-
dicts adherence to actions, including to medications. The 
time of day (morning vs. evening) may influence adher-
ence and habit strength to the degree that stability of 
contexts/routines varies throughout the day.
Purpose. The current study evaluates whether patients 
are more adherent to morning versus evening doses 
of medication and if  morning doses show evidence of 
greater habit strength than evening doses.
Methods. Objective adherence data (exact timing of pill 
dosing) were collected in an observational study by elec-
tronic monitoring pill bottles in a sample of patients on 
twice-daily pills for Type 2 diabetes (N  =  51) over the 
course of 1 month.
Results. Data supported the hypothesis that patients 
would miss fewer morning than evening pills. However, 
counter to the hypothesis, variability in dose timing (an 
indicator of habit strength) was not significantly dif-
ferent for morning versus evening pills.
Conclusions. Findings suggest that medication adher-
ence may be greater in the morning than in the evening. 
However, more research is needed to evaluate the role of 
habitual action in this greater adherence. Furthermore, 
future research should evaluate the validity of behavioral 
timing consistency as an indicator of habit strength.
Keywords:  Medication adherence ∙ Objective data ∙ 
Habit strength ∙ Habitual behavior ∙ Medication Event 
Monitoring Systems
Many of the behaviors that individuals engage in on a 
daily basis are habitual, that is, occurring automatically 
in response to learned contextual cues [1, 2]. Recent re-
search has focused on the importance of behavioral 
habit strength for health and other outcomes [3, 4]. This 
focus is warranted by both the theoretical and empirical 
importance of habits for behavioral engagement and 
outcomes: theory states that habits promote health be-
havior engagement and maintenance because they are 
nondeliberative, relatively efficient, frequent, and do not 
tax cognitive and self-regulatory resources to enact [5]. 
Empirical evidence shows that behavioral habit strength 
predicts behavior incrementally to (and in some cases 
more strongly than) conscious, reflective factors, such as 
behavioral intentions and beliefs or attitudes [6, 7].
Treatment nonadherence is pervasive, with an esti-
mated 50% of patients not adhering to daily medica-
tions for chronic illness management, and it contributes 
substantially to unnecessary health care costs [8, 9]. 
Recent research has demonstrated the importance of 
medication-taking routines, or habits, for long-term ad-
herence to treatments in several chronic illness domains 
(asthma: [10, 11]; Type 2 diabetes: [6]; hypertension: [12, 
13]). Therefore, researchers are now testing interventions 
to promote habit development (e.g., [14]), which could 
be used to improve treatment adherence. Simple, uni-
versal strategies have shown some promise at helping 
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individuals form new habits and break bad habits. For 
example, making action plans (e.g., “When I make coffee 
in the morning, then I will take my pills”) have helped in-
dividuals increase their level of physical activity, change 
their diets, and quit smoking (see [15] for a review). These 
interventions may be tailored to each individuals’ own 
goals and contexts (e.g., choosing meaningful, feasible, 
and personal cues for action). Piggybacking is a similar 
technique for forming a new habit that entails combining 
a new behavior with an existing habit or sequence of 
habitual actions (e.g., pairing flossing with one’s teeth-
brushing routine; [16]).
To-date, few researchers have investigated the pos-
sible influence of time-of-day (morning vs. evening) on 
successful habit formation. Differences in habitualness 
throughout the day could determine when it would be 
best to implement action plans. For example, piggy-
backing may be more successful if  the timing coincides 
with an individual’s most highly structured/repetitive 
time of day. Although no one has tested this in the pub-
lished literature, contexts (such as activities and location) 
may be more or less stable in the morning than in the 
evening. Anecdotally, one might expect individuals to 
have a stable time they get up in the morning because 
of work schedules but have a more variable dinner and 
bed time, depending on how the rest of the day unfolds 
(e.g., with disruptions in plans that may be more likely 
to occur as time passes). Unpublished data from Wood 
et  al. [2] indeed demonstrate that individuals showed 
their greatest number of habitual actions occur in the 
morning versus in the evening (with an average spike 
in habitual behavior between 7 and 9 am; personal com-
munications with study authors). Further, Domke et  al. 
[17] found that action-plan enactment was highest in 
the morning and decreased throughout the day, causing 
the authors to speculate that behavioral routines are 
more stable in the morning. Lastly, research by Fournier 
et al. [18] found that participants were quicker to form 
a simple habit (doing a stretch) when this was done in 
the morning compared to evening, potentially due to a 
facilitative effect of higher cortisol levels in the morning 
on habit formation.
Regarding time-of-day effects on treatment adherence, 
there are only two small studies, to our knowledge, that 
evaluated whether morning or evening routines were as-
sociated with greater adherence. Both studies were con-
ducted with patients on glaucoma medications. Kahook 
and Noecker [19] determined that nonrandomly assigned 
patients with morning routines had fewer missed days of 
treatment than patients with evening routines, although 
overall adherence was not significantly different between 
groups. Ford et al. [20] randomly assigned patients to a 
morning or evening routine and found that, although pa-
tients reported preferring the morning routine, there was 
no statistically significant difference in adherence by time 
of day. Lastly, although Ford et al. [20] had every par-
ticipant try a morning and an evening routine (1 month 
each; counter-balanced and randomly assigned order), 
their study design did not allow for a direct comparison 
within subject of morning versus evening routines; that 
is, trying one routine before another necessarily intro-
duces problems associated with forming a routine and 
then having to change that routine in order to try the 
alternative timing of the routine.
Existing research is limited in evaluating time-of-day 
factors because of the way habits and behaviors are typ-
ically measured, which is not specific to a particular time 
of day. For example, habit strength is measured with 
self-reports of the perceived automaticity or context sta-
bility of a particular action without reference to specific 
timing or context (e.g., “Taking my pill is something I do 
automatically: strongly disagree to strongly agree”; [21]). 
Furthermore, measures that ask whether individuals en-
gage in the behavior at the same time and in the same 
location each day (e.g., [22]) assume that there is only 
one relevant time point (behavior is done only once per 
day) and/or do not evaluate time-of-day effects. Most 
adherence data similarly do not allow evaluations of 
intraindividual differences, particularly on a daily meas-
urement level, since they utilize patient-reported adher-
ence measures as outcome variables (e.g., “In the past 
week, how many pills did you miss?”). Objective data 
from electronic monitors allow a fine-tuned and specific 
time-of-day look at adherence to medications and habit-
ualness (consistency) in pill timing. First, morning ac-
tivity can be separated from evening activity objectively. 
Second, exact timing and consistency of timing across 
days can be measured for each individual. The latter use 
of the monitors offers a proxy for habit strength. This 
use of time consistency (i.e., lower levels of variance in 
timing) as a measure of habit strength is supported by 
theory and evidence in the literature (e.g., [2, 22, 23]). 
Hoo et al. [23] recently utilized electronic data capture 
(EDC) from nebulizers to create a habit index created 
from the product of the timing stability of nebulizer use 
over a week’s time period with adherence (%  of days 
nebulizer used). Although this index utilized time sta-
bility as part of its calculation, a limitation of the index is 
that it also uses frequency of behavior in its calculation, 
which will be related to subsequent behavioral frequency 
for reasons other than habit strength (e.g., deliberative 
adherence mechanisms).
The purpose of the current study was to utilize an 
existing, rich data set that can evaluate the relation-
ship between the time of day and behavioral frequency 
and habit strength—namely, whether medication ad-
herence depends on dosing timing and whether there 
is evidence of greater habit strength in pill-taking be-
havior, operationalized as lower variation in the time 
a pill is taken from day-to-day (greater consistency of 
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pill timing indicating stronger routine/habit formation). 
Data from Medication Event Monitoring System bottles 
(MEMS bottles) in a sample of patients on twice-daily 
pills for Type 2 Diabetes were used to test the following 
hypotheses: For patients taking two pills per day [1], the 
number of missed doses (i.e., medication nonadherence) 
will be significantly greater for the evening dose than 
the morning dose, and [2] the variability (variance) in 
time the pill is taken will be significantly greater for the 
evening dose than the morning dose (i.e., habit strength 
will be weaker in the evening vs. morning).
Method
Participants and Procedure
Data are from an archived data set that utilized MEMS 
bottles for measuring patients’ adherence to medication. 
The data set has MEMS data for patients on Type 2 dia-
betes medication (pill form; e.g., Metformin). Twenty-
five patients in this data set were on a once-daily regimen 
and are excluded from analyses, which are within-person 
comparisons. Fifty-one patients were on a twice-daily 
regimen and were used to test the hypotheses. More de-
tails on the sample and procedure can be found in [6]. 
The analyses conducted in this paper are post hoc ana-
lyses of only the MEMS data and do not repeat any of 
the published relationships.
In the study, patients were recruited via patient re-
cords and were on existing treatments for their Type 2 
diabetes. Participants ranged in age from 30 to 70 years 
of age, approximately 50% completed a bachelor’s degree 
or higher education level, and a majority self-identified 
as Black/African heritage (70%) and female (59%).
Measures
Four variables were created [1]: the number of missed 
doses in the morning was calculated to represent adher-
ence to morning doses [2], the number of missed doses 
in the evening was calculated to represent adherence 
to evening doses [3], the patients’ variance in morning 
pill timing was calculated to represent [lack of] habit 
strength in taking the morning dose, and [4] the patients’ 
variance in evening pill timing was calculated to repre-
sent [lack of] habit strength in taking the evening dose. 
Although MEMS software (Powerview) allows export 
of exact times, the pill bottles were open, two coders 
went through these data to ensure that times were ap-
propriately allocated to morning versus evening doses. 
The coders were in agreement on 98% of cases. One pa-
tient had such highly variable data (times on which he/
she took the “morning” and “evening” pills) that it was 
difficult to assign “morning” versus “evening” status to 
pills that were taken or missed. This patient is one of the 
two univariate outliers on pill-timing variance, and so re-
sults were determined with and without his/her inclusion 
in the data as described below.
Baseline data from the Self-Reported Behavioral 
Automaticity Index (SRBAI; 21) were used to evaluate 
whether the variance measures of pill timing had con-
vergent validity with a widely used measure of habit 
strength. This self-reported measure was not specific to 
time of day (“Taking my medication is something I do 
automatically: strongly disagree (=1) to strongly agree 
(=5)” rather than “Taking my morning/evening dose is 
something I do automatically”) and so could not be used 
to test the hypotheses, which are regarding morning- and 
evening-specific pill-taking habit (within-person).
Statistical Analyses
The data are first evaluated for univariate and multivariate 
outliers. In the case of outliers, the data are analyzed with 
and without the outliers included as recommended in re-
cent literature on data transparency and reproducibility 
[24]. The hypotheses are tested with paired samples t-tests 
for the difference between patients’ morning and evening 
missed pills and between patients’ morning-dose timing 
variance and evening-dose timing variance, respectively.
Results
There were N = 51 patients on twice daily regimens with 
MEMS data. The modal number of days observed was 
28 days, mean of 27.8 days, ranging from 17 to 31 days. 
There were two univariate outliers (determined as having 
variances greater than 3 standard deviations [SDs] from 
the mean) in pill-timing variance. Skewness and Kurtosis 
values were high only for the pill-timing variance vari-
ables. When the outliers are removed, the skewness and 
kurtosis are acceptable. Variance in pill timing (both 
morning and evening) significantly correlated with self-
reported behavioral automaticity, with correlations ran-
ging between −0.24 and −0.40 (correlations were stronger 
when outliers were removed). Results are presented with 
and without outliers, when exclusion of outliers mean-
ingfully influenced the results.
Hypothesis 1
As hypothesized, the number of missed doses in the 
evening (average  =  5.27 pills, SD  =  6.01) was signifi-
cantly greater than the number of missed doses in the 
morning (average = 3.96 pills, SD = 4.62): paired sam-
ples t(50) = −2.41, p = .02, (two-tailed), Cohen’s d = 0.34.
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Hypothesis 2
The variability in dose timing did not significantly differ 
between patients’ morning and evening doses. With 
outliers excluded, the average variance for the morning 
dose  =  6.26  min (SD  =  4.12  min) and for the evening 
dose = 6.54 min (6.07 min) had a nonsignificant paired 
t-test: t(48)  =  0.36, p  =  .72 (two tailed) and a Cohen’s 
d = 0.05. With outliers included in the data, the average 
variance for the morning dose = 6.70 min (SD = 4.70 min) 
and for the evening dose = 7.26 min (SD = 7.46 min) had 
a nonsignificant paired t-test: t(50) = 0.59, p = .56 (two 
tailed), Cohen’s d = 0.08.
Discussion
Behavior is determined through automatic and conscious 
processes [3, 5]. Individuals may take medications out of 
habit and/or because of purposeful intentions to do so. 
Although researchers talk about habits versus nonhabits, 
habit strength is theoretically a continuum, and so be-
havioral action is likely multidetermined, particularly 
in real life, for which contexts are not always perfectly 
stable [2].
In the current study, it was proposed that individ-
uals on twice-daily, oral diabetes medication would be 
more adherent and more behaviorally consistent (have 
greater habit strength) in the morning than the evening. 
Regarding medication adherence, results indeed showed 
that there were fewer missed pills in the morning than 
in the evening within person. Participants did not re-
port issues in using the MEMS bottles that might offer 
an alternative explanation for these findings, but this is 
nonetheless possible. In the future, researchers should 
explicitly ask whether patients used this or other strategy 
that could have interfered with the validity of the 
MEMS data.
Regarding habit strength, data did not strongly sup-
port the hypothesis that habit strength for taking the 
morning pill would be greater than habit strength for 
taking the evening pill. There are several possible ex-
planations for why the variability in pill timing for the 
morning pill was statistically equivalent to variability in 
pill timing for the evening pill. First, it is possible that the 
effect of time-of-day on habit is too small to detect stat-
istically with a small sample. Second, the greater number 
of missed doses in the evening could plausibly have been 
due to a weaker habit in the evening as hypothesized, 
but any doses that were taken could have been taken in 
line with that weaker habit. That is, instead of variance 
in timing indicating weaker habit, the missed pills could 
themselves be indications of weaker habit (existence of 
disrupted, weaker routines). Third, the greater adherence 
in the morning may not have been due to stronger habits 
of pill taking but rather greater cognitive resources in 
the morning, such as self-regulation [25] or the presence 
of other habits [2], which would free cognitive resources 
for deliberative behaviors (such as remembering to take 
a pill).
Lastly, operationalizing habit strength as time con-
sistency may not be appropriate. Individuals may have 
tied taking a pill to a consistent routine, such as making 
coffee in the morning, or hygiene-related routines, but 
these routines themselves may have occurred at dif-
ferent times of the day across days. Taking pills could, 
therefore, still be habitual and even more habitual in the 
morning and, when evening habits were disrupted, the 
pill was forgotten entirely rather than remembered and 
taken at a later time (and so habit strength would be re-
flected in the number of missed pills but not variation in 
timing of the pills actually taken). This has potential im-
plications for the habit field in general for habit strength 
assessment. Specifically, if  the contexts that cue habitual 
actions are not tied to specific and stable times of day, 
then objective behavioral monitors may not provide valid 
measures of habit strength since they currently focus on 
behavioral timing (i.e., consistency of timing across days 
as in the current study). More complex objective assess-
ment of behavioral patterns may potentially be devel-
oped that include action location or allow assessment 
of preceding actions in combination with behavioral 
timing. These more complex behavioral patterns located 
within repeating contexts (that are not necessarily tied to 
a specific time of day) could potentially be used to assess 
habit strength and habit development over time. For ex-
ample, objective monitors could detect higher intensity 
physical activity and identify locational patterns of that 
activity across days to identify exercise habits. Electronic 
monitoring pill bottles could trigger a short survey to be 
texted to participants when they open the bottles to take 
their pills, asking where they were when they took the 
pills and what behaviors they had engaged in directly be-
fore taking their pills.
An interesting, separate question is whether specific 
times themselves or the passage of a specific amount of 
time can function as cues-to-action. However, it seems 
unlikely that a specific time itself  (without an associated 
activity or environmental factor) can be salient enough 
to automatically trigger an impulse to act.
Although the month-long, objective adherence data 
and within-person analyses were strengths of the cur-
rent study, the sample size was relatively small, and fu-
ture research should use these methods in larger samples, 
across illness domains to further evaluate the hypoth-
eses. Also, complexity of regimen and comorbidity were 
not assessed in this study; these factors could have in-
fluenced adherence differentially in the morning versus 
evening, such as if  complex regimens are more likely to 
become disrupted as the day goes on compared to sim-
pler regimens. Furthermore, it is possible that individ-
uals’ weekdays differ from weekends (or workdays differ 
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from days off  and so forth) and that this could have in-
fluenced pill-timing variance. A  post hoc analysis that 
used participants’ weekday data only did not alter the 
results for either hypothesis. Future research could look 
at more complex patterns of timing (consistency across 
some days but not others; of consistency from week to 
week rather than day to day). Furthermore, future re-
search could evaluate whether work status or other life 
characteristics might influence pill timing differentially 
for morning versus evening doses.
Future research could measure separately individuals’ 
intentions and habits for morning versus evening pills 
using methods such as ecological momentary assessment. 
Future research could also evaluate interindividual dif-
ferences that would influence optimal behavioral timing 
(during the day) for habit formation. For example, indi-
viduals’ diurnal preference (morningness–eveningness), 
conscientiousness, or preference for routine/structure 
in general may influence their relative ability to form a 
morning versus evening habit [26, 27].
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